Bone Fragility-Contractures-Arterial Rupture-Deafness (BCARD) Syndrome

Why it happens
Other names
Types
Causes
Common symptoms and signs
Diagnostic tests
Non-pharmacological treatments (therapies & others)
Drug treatments
Dietary molecular supplements
Drugs for immunity booster / regenerative / stem-cell
Surgeries
Preventions
When to see a doctor (or go to the ER)
What to eat and what to avoid
FAQs

Bone Fragility-Contractures-Arterial Rupture-Deafness (BCARD) Syndrome is a very rare, inherited connective-tissue disease. It happens when both copies of the PLOD3 gene stop working properly. PLOD3 makes the lysyl-hydroxylase-3 (LH3) enzyme, which helps collagen fibers get the right chemical changes to become strong and stretchy. When LH3 does not work, collagen is weak in many body parts. This can cause easy bone fractures (bone fragility), stiff joints (contractures), eye problems, skin fragility, artery aneurysms or sudden artery tears (arterial rupture), and sensorineural hearing loss (deafness). Most cases reported so far show autosomal recessive inheritance. Because collagen is everywhere, regular care must check bones, spine, eyes, skin, blood vessels, hearing, and growth. Orpha.net+3PMC+3NCBI+3

The science behind BCARD is simple to grasp: LH3 does two important jobs when collagen is being built—adding hydroxyl groups to lysine and adding sugars to those hydroxylysines. These steps help collagen strands form stable cross-links. If LH3 is missing, collagen cross-linking is poor, so tissues tear, stretch, or fracture under normal loads. This explains why bones break, joints contract or deform, and arteries can form aneurysms or rupture. PMC+1

Bone fragility-contractures-arterial rupture-deafness syndrome—often shortened to BCARD—is a very rare, inherited connective-tissue disorder. It mainly affects the skeleton (easy-to-break bones and joint contractures), the eyes (cataract and severe near-sightedness), the blood vessels (risk of aneurysm and dangerous arterial tears), and the inner ear (sensorineural hearing loss). Children can have low bone density, scoliosis, clubfoot, and stiff fingers or other joints. Many patients also have soft, easily bruised skin with shallow palm creases, and some have developmental delay related to vision or hearing problems. Doctors consider BCARD an autosomal recessive disease—both copies of a gene must be altered. NCBI

Why it happens

BCARD is caused by harmful changes in a gene called PLOD3. This gene makes an enzyme called lysyl hydroxylase 3 (LH3). LH3 helps “finish” collagen—the body’s main building fiber—by adding chemical groups to collagen so fibers can form strong cross-links and the matrix can be laid down correctly in bone, vessel walls, cornea/retina, skin, and the inner ear. When LH3 does not work, collagen is weak or poorly organized. That makes bones fragile, vessels prone to aneurysm/rupture, the eye’s lens and retina abnormal, and the inner ear’s sound-sensing structures vulnerable. PMC+2PMC+2

Other names

Doctors and databases use several labels for the same disorder:

BCARD syndrome (preferred short name). NCBI
Bone fragility with contractures, arterial rupture, and deafness (full name). NCBI
LH3 deficiency / Lysyl hydroxylase-3 deficiency (focuses on the enzyme problem). NCBI+1
Connective tissue disorder due to lysyl hydroxylase-3 deficiency (used by rare-disease registries). malacards.org

Types

There are no formally recognized clinical subtypes of BCARD right now. Instead, doctors see a spectrum from milder to more severe disease depending on the exact PLOD3 variants and how much LH3 function remains. Reports continue to expand the clinical range—especially for vascular, skin, and eye findings—so you may see patients described as “mild,” “moderate,” or “severe,” or grouped by their dominant complications (bone-predominant, vascular-predominant, ocular-predominant). Ovid+1

Causes

The root cause is biallelic pathogenic variants in PLOD3. Below are twenty concrete, easy-to-grasp mechanisms or precipitating factors that lead to BCARD features or worsen its complications.

Loss-of-function PLOD3 variants: the key disease cause, reducing or abolishing LH3 activity. malacards.org
Faulty lysine hydroxylation in collagen: collagen lacks needed hydroxylysine residues for strong cross-links. Frontiers
Defective collagen glycosylation: LH3 also adds sugars to collagen; without this step, the matrix assembles poorly. PMC
Weak bone matrix: poorly cross-linked type I collagen causes low bone mineral density and fractures. NCBI
Abnormal vessel wall collagen: fragile arteries predispose to aneurysm and rupture or dissection. NCBI
Lens and retinal matrix defects: lead to cataract, high myopia, and risk of retinal detachment. NCBI
Inner-ear collagen defects: damage cochlear structures, causing sensorineural hearing loss. NCBI
Abnormal skin anchoring fibrils: blistering/EB-like skin changes from disrupted collagen VII relationships have been reported. BioMed Central
Growth-plate and tendon matrix changes: contribute to clubfoot and fixed joint contractures. NCBI
Scoliosis from weak vertebral elements: unstable spinal matrix allows progressive curvature. BioMed Central
Craniofacial connective-tissue changes: create a recognizable facial pattern in some patients. NCBI
Diaphragmatic connective-tissue weakness: may cause diaphragmatic eventration. NCBI
Coagulation test abnormalities: prolonged PTT/abnormal PT have been observed, reflecting broader connective-tissue/vascular involvement. NCBI
Postnatal growth failure: secondary to systemic connective-tissue disease and sensory deficits. NCBI
CNS small-vessel changes: PLOD3 variants can contribute to cerebral small-vessel disease. Wiley Online Library
Hypertension (modifier): not a root cause, but high blood pressure can increase aneurysm/rupture risk in fragile arteries. (Clinical inference consistent with vascular-fragility disorders.) NCBI
Pregnancy hemodynamics (modifier): increased circulatory stress may heighten vascular risk in connective-tissue vasculopathies. (Reasoned extension; handle with specialist care.) NCBI
Major surgery/trauma (trigger): can precipitate fractures or vascular complications in fragile tissues. NCBI
Poor bone mineral accrual: reduced weight-bearing from contractures or fractures further weakens bone. NCBI
General ECM disorganization: LH3 deficiency broadly disrupts matrix deposition and organization across tissues. MDPI

Common symptoms and signs

Bones break easily after minor bumps because bone collagen is weak. NCBI
Low bone density (osteopenia) makes bones thin on scans. NCBI
Scoliosis develops as the spine curves over time. NCBI
Joint contractures (stiff, fixed joints—often fingers/feet) limit movement from birth or early childhood. NCBI
Clubfoot (talipes) may be present at birth and needs orthopedic care. NCBI
Arterial aneurysm or rupture can occur and is life-threatening. NCBI
Sensorineural hearing loss causes trouble hearing, usually in both ears. NCBI
Cataract clouds the lens and blurs vision early in life. NCBI
Severe myopia (very near-sighted) and abnormal vitreous increase retinal detachment risk. NCBI
Soft, easily bruised or blistered skin with reduced palmar creases in some patients. NCBI
Facial differences (recognizable pattern) may be noted by genetics teams. NCBI
Growth restriction before birth and postnatal growth delay after birth. NCBI
Diaphragmatic eventration in some cases, which can affect breathing mechanics. NCBI
Abnormal clotting tests (prolonged PTT or abnormal PT) on lab workups. NCBI
Developmental delay that often relates to reduced hearing/vision and medical complications. NCBI

Diagnostic tests

A) Physical-exam–based assessments

Whole-body exam by genetics/orthopedics to document fractures, scoliosis, and joint contractures; this establishes the connective-tissue pattern. NCBI
Foot exam for clubfoot (talipes) and gait; helps plan casting or surgery. NCBI
Skin exam for blistering, easy bruising, and reduced palmar creases. NCBI
Audiologic bedside screens (functional) to flag hearing loss early. NCBI
Ophthalmic slit-lamp exam to detect cataract and lens/segment abnormalities. NCBI

B) Manual/bedside tests

Goniometry/range-of-motion measurements to quantify contractures and track therapy response. NCBI
Spinal flexibility assessment (forward bend/Adam’s test) as a simple scoliosis screen before imaging. NCBI
Bedside tuning-fork tests (Rinne/Weber) to distinguish sensorineural from conductive hearing loss before formal audiology. (BCARD hearing loss is sensorineural.) NCBI
Vision charting and refraction to quantify high myopia. NCBI
Blood-pressure measurement to identify a modifiable vascular risk factor in fragile arteries. NCBI

C) Laboratory & pathological tests

Genetic testing—PLOD3 sequencing (and deletion/duplication analysis) is the diagnostic cornerstone; biallelic pathogenic variants confirm BCARD. malacards.org+1
Collagen biochemical studies (specialized labs) to evaluate collagen hydroxylation/glycosylation in fibroblasts when genetics is inconclusive. PMC
Coagulation profile (PT/INR and aPTT) because abnormalities are reported in BCARD. NCBI
Bone-turnover markers (e.g., alkaline phosphatase, P1NP/CTX) to characterize bone metabolism (supportive, not specific). (Informed by OI/low-bone-mass workups.) Wikipedia
Basic metabolic panel, calcium, phosphate, 25-OH vitamin D to rule out other contributors to low bone density. (General bone fragility practice.) Wikipedia

D) Electrodiagnostic tests

Auditory brainstem response (ABR)—objective, electrode-based test to confirm sensorineural loss in infants or those who cannot do standard audiometry. NCBI
Otoacoustic emissions (OAE)—quick cochlear outer-hair-cell test complementing ABR/audiometry. NCBI
Electroretinography (ERG) in selected cases if retinal function is a concern in the BCARD ocular spectrum. NCBI

E) Imaging tests

Skeletal survey (X-rays) to document fractures, bone deformities, and vertebral changes. NCBI
DXA (bone-density scan) to quantify osteopenia/osteoporosis in a child-appropriate protocol. NCBI
Spine radiographs to measure scoliosis progression and guide bracing/surgery timing. BioMed Central
Echocardiography as a first-line, radiation-free vascular screen (aortic root size, valves) in connective-tissue vasculopathy. (Standard in aneurysm-risk disorders.) NCBI
CT or MR angiography (head/neck/chest/abdomen/pelvis) to look for arterial aneurysms or dissections when symptoms or screening warrant. NCBI
Vascular Doppler ultrasound for accessible arteries (e.g., carotids) as a surveillance tool. NCBI
Ophthalmic imaging (OCT, fundus photography; ultrasound B-scan if needed) to monitor retina/vitreous and pre-op cataract planning. NCBI

Non-pharmacological treatments (therapies & others)

Aortic/arterial imaging surveillance
Regular imaging (echo/CT/MR) helps spot aneurysms before they rupture. In heritable aortopathy, scheduled surveillance and threshold-based repair reduce catastrophic events. For BCARD, clinicians adapt the 2022 ACC/AHA aortic disease guideline to individual risk. AHA Journals+1
Strict blood-pressure control (lifestyle)
Even before medicines, lowering dietary salt, healthy weight, regular low-impact exercise, and avoiding stimulants help lower wall stress on arteries, a key goal in heritable vascular disorders. This aligns with aortic disease prevention principles. AHA Journals
Emergency action plan
Families should keep a written plan describing the disorder, rupture warning signs (sudden chest/abdominal/back pain, neurologic deficit), and preferred centers. Rapid triage reduces time to imaging and repair in acute aortic syndromes. AHA Journals
Bone-protective physical therapy
Therapy focuses on safe movement, posture, core strengthening, and fall prevention to cut fracture risk while preserving mobility in low BMD states, an approach borrowed from OI management programs. Cochrane
Spine monitoring and bracing
Progressive scoliosis may need bracing and careful follow-up; in severe curvature, multidisciplinary planning is vital due to tissue fragility, as shown in LH3-deficiency case management. BioMed Central
Fracture prevention education
Use protective gear, home fall-proofing, and lifting/transfer training. These simple steps reduce fractures in brittle-bone conditions. Cochrane
Optimized calcium and vitamin D intake
Meeting age-appropriate calcium and vitamin D needs supports bone mineralization; exceedance can be harmful, so dosing follows NIH ODS guidance. Office of Dietary Supplements+1
Nutrition for bone and vessel health
Balanced protein, fruits/vegetables, and foods rich in omega-3 fatty acids may support cardiovascular health while maintaining bone-friendly nutrients. Office of Dietary Supplements
Audiology rehabilitation
Early hearing evaluation with hearing aids or assistive devices improves communication; cochlear implant may be considered for severe loss. NIDCD+1
Eye care and retinal detachment precautions
High myopia/cataract need routine ophthalmology care; urgent care for flashes/floaters or curtain vision aligns with BCARD ocular risks reported in summaries. Genetic & Rare Diseases Info Center
Skin protection and wound care
Gentle skin care and blister prevention mirror approaches used for epidermolysis-like phenotypes reported in PLOD3 literature. ScienceDirect
Activity modification
Avoid high-impact/valsalva heavy lifting that spikes aortic pressure; prefer low-impact exercise (walking, swimming) per aortic-disease risk reduction principles. AHA Journals
Genetic counseling for families
BCARD is autosomal recessive; counseling supports carrier testing and future family planning. NCBI
Peri-operative planning
If surgery is needed, teams anticipate friable tissues, careful hemostasis, and gentle positioning. Protocols mirror connective-tissue and aortic-disease best practices. AHA Journals
Bone-safe dentistry
Before any bisphosphonate or denosumab, counsel on dental hygiene to lower rare osteonecrosis-of-jaw risk reported on labels. FDA Access Data
Pain self-management
Use pacing, heat/cold, and supported positioning first; add drug therapy only as needed and bone-safe. Cochrane
Vaccinations & infection prevention
Infections can trigger coughing/straining and falls; routine immunizations reduce those indirect risks and protect overall health. (General preventive rationale.) AHA Journals
School and workplace accommodations
Written supports (rest breaks, seating, lifting limits, accessibility) prevent injuries and hearing-related communication barriers; assistive listening devices help. MagicApp Files
Mental-health support
Living with a rare disorder is stressful; counseling and peer support improve adherence and quality of life. (General chronic-disease evidence base.) American Academy of Family Physicians
Regular multidisciplinary clinics
Coordinated clinics improve surveillance and early treatment across bones, vessels, hearing, and eyes—key for multi-system collagen disorders. Genetic & Rare Diseases Info Center

Drug treatments

Important: No medicine is FDA-approved for BCARD itself. The medicines below are used to treat features (hypertension/aortic risk, low BMD, pain) and are cited to FDA labels for dosing/safety in their approved indications. Use off-label only under specialist care.

Losartan (ARB) – lowers blood pressure, reducing aortic wall stress; typical adult start 50 mg daily, titrate. Label shows indications and common adverse effects (hyperkalemia, hypotension). Used off-label in heritable aortopathy care plans. FDA Access Data+1
Amlodipine (CCB) – useful add-on when ARB/β-blocker insufficient; start 5 mg daily. Label details indications (hypertension/angina) and hypotension/edema risks. FDA Access Data+1
Metoprolol tartrate (β-blocker) – slows heart rate and reduces dP/dt (shear), lowering aortic stress; typical dosing 50–100 mg twice daily per label, with cautions on abrupt withdrawal. FDA Access Data+1
Labetalol (α/β-blocker) – helpful for tighter BP control or peri-operative settings; oral and IV labels give dosing and precautions (orthostasis, bronchospasm). FDA Access Data+1
Alendronate (bisphosphonate) – increases BMD in osteoporosis; weekly dosing per label (e.g., 70 mg once weekly), taken upright with water; ONJ/atypical femur warnings. Extrapolated to severe bone fragility. FDA Access Data+1
Zoledronic acid (Reclast) – annual IV dosing for osteoporosis; label shows fracture-risk reduction data and renal monitoring needs. Used off-label when adherence to orals is hard. FDA Access Data+1
Risedronate (Actonel/Atelvia) – oral bisphosphonate alternative with label dosing (daily/weekly or delayed-release). Similar safety and administration rules. FDA Access Data+1
Pamidronate (Aredia) – IV bisphosphonate used in pediatric brittle-bone programs; label provides dosing and infusion cautions (electrolytes/renal). Specialist use only. FDA Access Data+1
Acetaminophen – first-line analgesic for fractures/joint pain because it does not impair bone healing nor platelets; labels stress hepatotoxicity risk with overdosing. U.S. Food and Drug Administration+1
Tranexamic acid – antifibrinolytic useful peri-operatively or with mucosal bleeding; label (LYSTEDA) provides oral dosing and thrombotic cautions (indicated for heavy menses, off-label elsewhere). FDA Access Data+2FDA Access Data+2
Vitamin D3 (cholecalciferol) – treat deficiency to support bone mineralization; dosing individualized to labs; see FDA-regulated combination labeling and NIH dosing limits to avoid toxicity. FDA Access Data+1
Calcium supplements – used if diet is insufficient; ensure totals meet age-based targets and avoid excess; regulatory and ODS resources outline safe ranges. Office of Dietary Supplements+1
Topical anesthetics for wound care – short-term use can aid skin procedures on fragile tissue; follow specific product labels for dosing and methemoglobinemia warnings. (General label principle.) American Academy of Family Physicians
Antihypertensive combinations – if single agents fail, combine (e.g., ARB + CCB) per BP labels; tighter control protects aorta. FDA Access Data+1
Peri-operative beta-blockade – in high-risk vascular cases, titrated β-blockers blunt surges; see β-blocker labels for IV/oral conversions and cautions. FDA Access Data
Analgesic ladder (short opioid courses) – reserve for acute fractures only; follow opioid label warnings about dependence/respiratory depression. FDA Access Data
Antihypertensive IV agents (labetalol) – for acute BP spikes/rupture care per label dosing protocols in monitored settings. FDA Access Data
Proton-pump inhibitor if long-term NSAID is unavoidable – GI protection per label; however, try to minimize NSAIDs in fracture-healing periods. (Label-based risk reduction.) American Academy of Family Physicians
Loop diuretic caution – in fragile patients, rapid shifts may worsen orthostasis/fall risk; follow labels and use only for clear indications (heart/renal). (Label-based caution.) American Academy of Family Physicians
Vaccines (per label schedules) – protect health and reduce infection-related deconditioning that can trigger falls/strain; follow CDC/FDA labeling and schedules. (Label-based preventive principle.) American Academy of Family Physicians

Background evidence for bone medicines: Bisphosphonates improve BMD in OI and other fragility states (fracture reduction evidence is mixed), so clinicians sometimes extrapolate cautiously to BCARD. Cochrane+2PubMed+2

Dietary molecular supplements

Vitamin D3 (cholecalciferol) – supports calcium absorption and bone mineralization; excess causes hypercalcemia, so follow lab-guided dosing and UL limits from NIH ODS. Office of Dietary Supplements
Calcium (elemental) – achieve age-appropriate intake with diet first, then supplement if needed; excess may cause constipation or kidney stones; see NIH ODS targets. Office of Dietary Supplements
Magnesium – assists bone matrix and vitamin D metabolism; avoid excess (diarrhea, in CKD risk); follow NIH ODS guidance. Office of Dietary Supplements
Vitamin C – needed for collagen hydroxylation chemistry; routine high-dose use is not proven for bone, and very high doses can cause GI upset or stones; follow NIH ODS limits. Office of Dietary Supplements
Omega-3 fatty acids (EPA/DHA) – general cardiovascular benefit signals; use food sources or supplements within NIH ODS ranges; watch antiplatelet interactions. Office of Dietary Supplements
Protein optimization – adequate protein supports bone healing; balanced diet guidance per NIH ODS pages (calcium/vitamin D context). Office of Dietary Supplements+1
Vitamin K (dietary) – important in bone protein carboxylation; no BCARD-specific data; keep a consistent intake and avoid excess without supervision. (General ODS-aligned principle.) Office of Dietary Supplements
Zinc – supports wound and bone repair; avoid high chronic dosing; align with NIH fact-sheet limits. (General nutrient safety principle.) Office of Dietary Supplements
B-complex (esp. B6, B12, folate) – supports general tissue health; correct deficiency states per standard nutrition references. (General NIH ODS rationale.) Office of Dietary Supplements
Collagen peptides – popular but evidence for fracture reduction is limited; can be used as a food supplement, not a drug; prioritize proven nutrients first. (General nutrition evidence context.) Office of Dietary Supplements

Drugs for immunity booster / regenerative / stem-cell

Vitamin D repletion – correct deficiency to support immune and musculoskeletal function; dose guided by 25-OH-D levels and NIH ODS limits. (Not a “booster,” but deficiency harms bone.) Office of Dietary Supplements
Calcium with vitamin D – foundational for mineralization; use the lowest dose to meet the target intake and avoid excess. Office of Dietary Supplements
Bisphosphonates (e.g., zoledronic acid) – anti-resorptive, not regenerative; they stabilize bone microarchitecture and raise BMD. Use per labels in osteoporosis; off-label in severe fragility. FDA Access Data
Teriparatide (PTH 1-34) – an anabolic bone drug for severe osteoporosis in adults; daily injections for limited duration. Not studied in BCARD; pediatric use is restricted. (Label-based class information via osteoporosis standards.) American Academy of Family Physicians
Denosumab – anti-resorptive monoclonal antibody for osteoporosis; requires adherence to dosing and rebound-fracture prevention plan on discontinuation; off-label caution in BCARD. (Label-based class information.) American Academy of Family Physicians
Peri-operative tranexamic acid – not regenerative, but reduces blood loss for people with fragile tissues undergoing surgery; follow label precautions. FDA Access Data

Note: Stem-cell therapies are not established for BCARD. Any such use should be in approved clinical trials only. (Ethical/practice standard.) Genetic & Rare Diseases Info Center

Surgeries

Endovascular aneurysm repair (EVAR) or open vascular repair – done when imaging shows aneurysms or acute dissection/rupture meets guideline thresholds. Goal: prevent or stop life-threatening bleeding. Tissue fragility demands experienced centers. AHA Journals
Spinal fusion for severe scoliosis – indicated for progressive curves causing pain or organ compression; LH3-deficiency case care highlights careful planning and peri-operative management. BioMed Central
Intramedullary rodding for long-bone deformity/fracture patterns – extrapolated from OI practice to stabilize frequent fractures and improve function when conservative care fails. Cochrane
Cochlear implantation – for severe/profound sensorineural deafness when hearing aids do not provide benefit; improves access to sound and speech development. NIDCD
Ophthalmic surgery (e.g., cataract extraction, retinal repair) – treats lens opacity and retinal tears/detachment associated with BCARD ocular features to preserve vision. Genetic & Rare Diseases Info Center

Preventions

Keep blood pressure in the target range every day. AHA Journals
Do scheduled aortic/arterial imaging and never skip follow-ups. Sochicar
Choose low-impact exercise; avoid heavy straining/valsalva. AHA Journals
Use fall-prevention at home (lighting, rails, no loose rugs). Cochrane
Meet calcium + vitamin D intake goals; avoid megadoses. Office of Dietary Supplements+1
Early hearing care with devices or implants if needed. NIDCD
Eye checks for high myopia/cataract; urgent care for detachment signs. Genetic & Rare Diseases Info Center
Dental care before/while on anti-resorptives to lower ONJ risk. FDA Access Data
Keep a medical alert card listing “LH3 (PLOD3) connective-tissue disorder.” NCBI
Plan pregnancy and anesthesia with high-risk obstetrics/anesthesiology due to vascular risk. AHA Journals

When to see a doctor (or go to the ER)

Seek immediate emergency care for sudden severe chest, back, abdomen, or head pain; fainting; stroke signs (weakness, difficulty speaking); or sudden vision loss—these can indicate aneurysm, dissection, or rupture. Call or see your clinician urgently for new or worsening bone pain, suspected fracture, rapid curve in the spine, new hearing drop, eye flashes/floaters, or uncontrolled blood pressure. These warnings follow aortic-disease and BCARD feature profiles. AHA Journals+1

What to eat and what to avoid

Do eat calcium-rich foods (dairy, fortified plant milks, tofu with calcium, leafy greens) to hit age-based targets. Office of Dietary Supplements
Do eat vitamin-D sources (fortified foods; oily fish) or take supplements if advised by your clinician. Office of Dietary Supplements
Do include protein at every meal for bone repair (fish, eggs, legumes, lean meats). Office of Dietary Supplements
Do add omega-3 foods (fish, flax, chia) for heart/vascular health. Office of Dietary Supplements
Do limit salt to help blood-pressure control. AHA Journals
Avoid very high vitamin-D doses unless prescribed (risk of hypercalcemia). Office of Dietary Supplements
Avoid excess alcohol and smoking; both harm bones and vessels. (General guideline-consistent.) AHA Journals
Avoid crash diets; maintain steady nutrition for bone health. (Bone-health principle.) Cochrane
Be careful with high-dose vitamin C (GI and stone risk in some); stay within ULs. Office of Dietary Supplements
Coordinate any supplements with your clinician to avoid interactions. (ODS safety principle.) Office of Dietary Supplements

FAQs

1) Is BCARD the same as Ehlers-Danlos or osteogenesis imperfecta?
No. It overlaps in features but is caused by PLOD3/LH3 defects that impair collagen post-translational modification. PMC

2) How is BCARD diagnosed?
By clinical features plus genetic testing showing biallelic PLOD3 pathogenic variants. NCBI

3) Is there a cure?
No cure yet. Care focuses on surveillance, blood-pressure control, bone protection, hearing/eye care, and timely surgery when needed. AHA Journals+1

4) What is the biggest life-threatening risk?
Arterial aneurysm, dissection, or rupture—this is why imaging and BP control are essential. AHA Journals

5) Are there medicines that fix collagen in BCARD?
No approved disease-modifying drugs. Treatments manage features (BP, bone fragility, pain). Genetic & Rare Diseases Info Center

6) Do bisphosphonates help?
They improve BMD and are used in other fragility disorders; fracture reduction evidence is mixed. Use only under specialist guidance. Cochrane+1

7) Can children receive the same drugs as adults?
Not always. Some drugs (e.g., teriparatide) are restricted; pediatric bone programs often use IV bisphosphonates with careful monitoring. FDA Access Data

8) What hearing treatments work?
Hearing aids help many; cochlear implants help severe loss when aids fail. Early audiology improves outcomes. NIDCD

9) How often should arteries be imaged?
Frequency is individualized; aortic-disease guidelines guide intervals based on size, growth, and symptoms. AHA Journals

10) What exercises are safe?
Low-impact (walking, swimming). Avoid heavy lifting/straining to limit sudden BP spikes. AHA Journals

11) Are pregnancies high risk?
Yes—arterial risks require preconception counseling and high-risk obstetric care. AHA Journals

12) What about skin and eye care?
Gentle skin care and prompt eye care for myopia/cataract/retinal symptoms are important. ScienceDirect+1

13) Should family members get tested?
Yes—autosomal recessive inheritance means siblings may be carriers or affected. Genetic counseling is recommended. NCBI

14) Are there clinical trials?
Check with genetics centers and trial registries; BCARD reports are increasing, but interventional trials are scarce. PubMed

15) What’s the most important daily habit?
Keep blood pressure controlled and attend scheduled imaging. These steps save lives. AHA Journals

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.